TrialJournal of the National Cancer Institute2022

Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.

Matteo Lambertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.